Indeed, we found significant amounts of TGF‐β were released by all four cancer cell lines tested here, with 2.4 to 4.3 fold increases compared to standard control media (Figure2A, with concentrations in Figure S2, Supporting Information). The gene discussed is TGFB1; the disease is cancer.